Rekah Pharmaceutical Industry Ltd. (TLV:REKA)

TLV:REKA Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	7.76	7.03	19.31	20.21	18.6	36.89
Short-Term Investments	0.04	-	-	-	-	-
Trading Asset Securities	-	0.04	0.04	0.08	0.04	0.04
Cash & Short-Term Investments	7.8	7.07	19.35	20.29	18.64	36.93
Cash Growth	-29.59%	-63.48%	-4.63%	8.83%	-49.53%	44.22%
Accounts Receivable	124.26	127.11	117.68	120.71	107.37	87.63
Other Receivables	8.76	8.55	8.67	6.83	2.25	1.98
Receivables	133.01	135.66	126.35	127.54	109.62	89.61
Inventory	87.38	82.48	96.6	92.2	89.61	97.85
Prepaid Expenses	-	2.63	1.94	1.83	1.42	0.71
Other Current Assets	-	1.22	7.09	1.28	2.37	2.25
Total Current Assets	228.2	229.05	251.33	243.14	221.66	227.35
Property, Plant & Equipment	135.46	140.07	154.62	163.21	177	181.82
Long-Term Investments	1.18	1.18	1.17	-	-	1.84
Goodwill	35.14	35.14	35.14	15.18	-	-
Other Intangible Assets	24.23	25.7	31.66	20.67	32.97	4.18
Long-Term Deferred Tax Assets	12.36	16.07	10.79	6.22	5.46	4.5
Other Long-Term Assets	-	-	0.01	0.01	0.01	0.01
Total Assets	436.57	447.22	484.72	448.42	437.09	419.69
Accounts Payable	97.11	87.52	78.89	81.21	57.44	59.89
Accrued Expenses	-	20.98	23.95	17.05	13.61	12.96
Short-Term Debt	23	14.35	3.12	-	0.01	5
Current Portion of Long-Term Debt	-	15.2	24.8	30.9	18.96	22.06
Current Portion of Leases	7.23	7.29	6.9	5.59	5.03	4.82
Current Income Taxes Payable	0.39	0.35	1.56	0.76	0.26	0.96
Current Unearned Revenue	-	0.24	0.13	0.1	0.25	0.88
Other Current Liabilities	24.33	12.13	4.45	3.44	3.04	1.7
Total Current Liabilities	152.06	158.04	143.79	139.03	98.61	108.26
Long-Term Debt	65.88	63.62	110.09	91.66	101.23	90.86
Long-Term Leases	32.16	33.7	38.76	37.55	40.6	43.6
Long-Term Deferred Tax Liabilities	1.8	5.27	6.03	2.75	3.16	-
Other Long-Term Liabilities	14.08	14.02	20.74	6.49	11.21	2
Total Liabilities	276.96	285.24	329.14	286.34	264.03	254.1
Common Stock	13.64	13.64	13.64	13.64	13.64	13.64
Additional Paid-In Capital	126.61	126.61	126.61	126.61	126.61	126.61
Retained Earnings	18.81	21.19	14.67	21.35	32.73	25.69
Treasury Stock	-0.51	-0.51	-0.51	-0.51	-0.51	-0.51
Comprehensive Income & Other	1.01	0.99	1.12	0.93	0.54	0.09
Total Common Equity	159.57	161.93	155.54	162.03	173.01	165.53
Minority Interest	0.05	0.05	0.05	0.05	0.05	0.06
Shareholders' Equity	159.62	161.98	155.59	162.08	173.07	165.59
Total Liabilities & Equity	436.57	447.22	484.72	448.42	437.09	419.69
Total Debt	128.27	134.16	183.66	165.7	165.82	166.34
Net Cash (Debt)	-120.47	-127.09	-164.31	-145.41	-147.18	-129.41
Net Cash Per Share	-10.42	-11.13	-14.39	-12.74	-12.89	-11.34
Filing Date Shares Outstanding	11.48	11.41	11.41	11.41	11.41	11.41
Total Common Shares Outstanding	11.48	11.41	11.41	11.41	11.41	11.41
Working Capital	76.14	71.01	107.54	104.11	123.05	119.09
Book Value Per Share	13.90	14.19	13.63	14.19	15.16	14.50
Tangible Book Value	100.19	101.09	88.73	126.18	140.05	161.35
Tangible Book Value Per Share	8.73	8.86	7.77	11.05	12.27	14.14
Land	-	1.89	1.89	2.07	2.07	2.07
Buildings	-	119.29	117.94	124.71	122.66	119.21
Machinery	-	125.12	121.03	112.99	109.84	106.6
Leasehold Improvements	-	63.16	61.15	58.28	57.23	54.74

Source: S&P Global Market Intelligence. Standard template. Financial Sources.